Upsher-Smith Is Honored With Prestigious Industry Award For Leadership And Innovation
MAPLE GROVE, Minn., June 5, 2013 /PRNewswire/ -- Upsher-Smith Laboratories, Inc. today announced that it is the recipient of a Distribution Industry Award for Notable Achievements in Healthcare (DIANA) given by the Healthcare Distribution Management Association (HDMA). The Company was presented with a DIANA for the "Best Overall Branded Pharmaceutical Product Manufacturer with Sales to Healthcare Distributors of Less Than $300 Million." The Company was also recognized as the First Merit Finalist for the "Best Overall Consumer Product Manufacturer with Sales to Healthcare Distributors of More Than $10 Million." The HDMA recognized leading pharmaceutical and consumer product manufacturers with the presentation of 10 DIANA Awards at its 2013 Business and Leadership Conference in Orlando, Florida on June 3.
For more than 50 years, the DIANA Awards have been presented to healthcare and consumer product manufacturers that set the standard for excellence in new product introductions and promotions. DIANA winners are chosen by HDMA distributor members who judge companies based on several criteria including: knowledgeable salespeople, high-level customer service, demonstrated flexibility and creativity in marketing, and incorporation of new technologies to ensure product safety and security. Upsher-Smith is included among a distinguished group of past recipients who serve as models for leadership and innovation in the healthcare marketplace.
"We would like to thank the HDMA members for selecting us for this DIANA Award because it is powerful acknowledgement of our commitment to the people who rely on us and our products," said Tom Burke, COO, Upsher-Smith Laboratories, Inc. "We have talented and dedicated employees who are passionate about serving the needs of our supply chain partners."
Upsher-Smith, founded in 1919, is an independent and privately-owned specialty pharmaceutical company headquartered in Maple Grove, Minnesota that focuses on product growth and innovation for branded and generic pharmaceuticals. Upsher-Smith has a particular focus on developing therapies to assist people suffering from central nervous system diseases and also markets products relating to cardiology, dermatology, and women's health. For more information, visit www.upsher-smith.com.
HDMA is the national association representing primary healthcare distributors, the vital link between the nation's pharmaceutical manufacturers and healthcare providers. Each business day, HDMA member companies ensure that nine million prescription medicines and healthcare products are delivered safely and efficiently to more than 200,000 pharmacies, hospitals, long-term care facilities, clinics and others nationwide. HDMA and its members work daily to provide value and achieve cost savings, an estimated $42 billion each year to our nation's healthcare system.
SOURCE Upsher-Smith Laboratories, Inc.
More by this Source
Upsher-Smith To Present Findings From Global Phase 3 Trial Investigating USL255 (Extended-Release Topiramate) For Adjunctive Treatment Of Epilepsy In Patients With Refractory Partial-Onset Seizures At 2013 American Epilepsy Society Meeting
Nov 05, 2013, 09:00 ET
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.